Quantum BioPharma Ltd. (QNTM)

NASDAQ: QNTM · Real-Time Price · USD

3.660

-0.060 (-1.61%)

At close: Sep 18, 2026, 4:00 PM EDT

3.620

-0.040 (-1.09%)

After-hours: Sep 18, 2026, 7:50 PM EDT

Quantum BioPharma Employees

Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year.

Employees

17

Change (1Y)

7

Growth (1Y)

70.00%

Revenue / Employee

n/a

Profits / Employee

-$1,479,927

Market Cap

29.60M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)	Full-Time	Part-Time
Dec 31, 2022	17	7	70.00%	17	0
Dec 31, 2021	10	1	11.11%	10	0
Dec 31, 2020	9	-9	-50.00%	9	0
Dec 31, 2019	18	-1	-5.26%	17	1
Sep 30, 2019	23	4	21.05%	23	0
Jun 30, 2019	19	-	-	19	0
Dec 31, 2018	19	-	-	19	0

Related Stocks

Company Name	Employees
Aligos Therapeutics	82
IGC Pharma	70
Evaxion	46
BeyondSpring	44
NextCure	40
Quince Therapeutics	38
Kyntra Bio	34
ABVC BioPharma	19

Employee Rankings

QNTM News

2 days ago - Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target - GlobeNewsWire
4 days ago - Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto - Newsfile Corp
5 days ago - NetworkNewsAudio Announces Audio Press Release (APR) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating ‘Rare Moment' in MS Research - GlobeNewsWire
8 days ago - Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials - GlobeNewsWire
10 days ago - Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment - GlobeNewsWire
18 days ago - Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange - GlobeNewsWire
19 days ago - Quantum Group initiated with a Buy at Rodman & Renshaw - TheFly
4 weeks ago - Quantum Biopharma Provides Corporate Update - GlobeNewsWire